ARTICLE | Company News
Biovitrum, Symphogen manufacturing deal
May 10, 2004 7:00 AM UTC
Biovitrum (Stockholm, Sweden) will manufacture a rhesus D-specific recombinant polyclonal antibody for Symphogen (Copenhagen, Denmark). The antibody is in preclinical development to prevent hemolytic ...